Björn Granseth

Björn Granseth

Auto-generated profile, based on publicly available information

Björn Granseth

Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2006 in Neuron
Verified
Journal Article
Closed access
BGBjörn Granseth
Björn Granseth
BOBenjamin Odermatt
Benjamin Odermatt
SRStephen J. Royle
Stephen J. Royle
LLLeon Lagnado
Leon Lagnado

27 June 2012 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SNSangeeta Nath
Sangeeta Nath
LALotta Agholme
Lotta Agholme
FKFiroz Roshan Kurudenkandy
Firoz Roshan Kurudenkandy
BGBjörn Granseth
Björn Granseth
JMJan Marcusson
Jan Marcusson
MHMartin Hallbeck
Martin Hallbeck
Alzheimer's disease (AD) is the major cause of dementia. During the development of AD, neurofibrillary tangles progress in a fixed pattern, starting in the transentorhinal cortex followed by the hippocampus and cortical areas. In contrast, the deposition of β-amyloid (Aβ) plaques, which are the other histological hallmark of AD, does not follow the same strict spatiotemporal pattern, and it correlates poorly with cognitive decline. Instead, soluble Aβ oligomers have received increasing attention as probable inducers of pathogenesis. In this study, we use microinjections into electrophysiologically defined primary hippocampal rat neurons to demonstrate the direct neuron-to-neuron transfer of soluble oligomeric Aβ. Additional studies conducted in a human donor–acceptor cell model show that this Aβ transfer depends on direct cellular connections. As the transferred oligomers accumulate, acceptor cells gradually show beading of tubulin, a sign of neurite damage, and gradual endosomal leakage, a sign of cytotoxicity. These observations support that intracellular Aβ oligomers play a role in neurodegeneration, and they explain the manner in which Aβ can drive disease progression, even if the extracellular plaque load is poorly correlated with the degree of cognitive decline. Understanding this phenomenon sheds light on the pathophysiological mechanism of AD progression. Additional elucidation will help uncover the detailed mechanisms responsible for the manner in which AD progresses via anatomical connections and will facilitate the development of new strategies for stopping the progression of this incapacitating disease.

12 December 2008 in The Journal of Physiology
Verified
Journal Article
Closed access
BGBjörn Granseth
Björn Granseth
LLLeon Lagnado
Leon Lagnado

6 August 2008
Verified
Book Chapter
Closed access
PDF file
SRStephen J. Royle
Stephen J. Royle
BGBjörn Granseth
Björn Granseth
BOBenjamin Odermatt
Benjamin Odermatt
ADAude Derevier
Aude Derevier
LLLeon Lagnado
Leon Lagnado

23 September 2017 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
SSSofie Charlotte Sundberg
Sofie Charlotte Sundberg
SLSarah Helen Lindström
Sarah Helen Lindström
GSGonzalo Manuel Sanchez
Gonzalo Manuel Sanchez
BGBjörn Granseth
Björn Granseth

14 December 2007 in The Journal of Physiology
Verified
Journal Article
Closed access
BGBjörn Granseth
Björn Granseth
BOBenjamin Odermatt
Benjamin Odermatt
SRStephen J. Royle
Stephen J. Royle
LLLeon Lagnado
Leon Lagnado